Industry Verticals »

All Categories

Insights »

About TMR »

Biopsy Devices Market

Biopsy Devices Market (Disposable & Reusable Needles, Hot & Cold Forceps, Needle-based Biopsy Guns, VAB, CNB, FNAB Devices, Guidance Systems) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018

Biopsy forms the first step in cancer diagnosis and subsequent treatment. The huge potential of the market for biopsy devices could be substantiated by its global market value of USD 1,347 million in 2011 and an expected CAGR of 6.6% from 2012 - 2018. North America is the leading regional market; however, with a remarkable growth rate, the Asian region is expected to record maximum growth due to the favourable demographic and economic conditions. C R Bard Inc. and Devicor Medical Products lead the biopsy devices market, closely followed by CareFusion Corporation and Hologic Inc. 

The major product categories in this market include needle-based guns, needles, forceps, guidance systems and others. Needle-based biopsy guns form the fastest growing segment in this market. The market is largely driven by change in consumer preferences, such as shifting from reusable devices to disposable devices. 

Growth of this market is directly proportional to the rate of cancer, which is growing rapidly, thus expanding the patient (consumer) base for biopsy devices. Majority of the cancer deaths globally can be prevented with early diagnosis and biopsy, enabling formulation of a proper treatment plan. Rising awareness and growing aging population are other major factors responsible for growth of this market globally. 

C R Bard Inc. dominates the market with its subsidiary Bard Biopsy Systems dedicatedly involved in manufacturing and distribution of biopsy devices in the major regional markets of North America and Europe. Affordability of expensive healthcare surgeries in developed and affluent countries of North America and Europe has propelled innovation and research in the field of biopsy. Asia is expected to witness a high growth rate with its simultaneous increase in population and cancer rate. Continuous advancements in technology and economic development are other prime factors driving growth of the biopsy devices market in Asia.

    Table of Content


    Chapter 1 Preface

    1.1 Report Description

    1.2 Market Segmentation

    1.3 Research Methodology

     

    Chapter 2 Executive Summary

     

    Chapter 3 Market Overview

    3.1 Introduction

    3.2 Market Drivers

          3.2.1 Increasing Incidence of Cancer Cases Worldwide

          3.2.2 Rising Public Awareness about Diseases and Screenings Conducted for the Same

          3.2.3 Increasing Preference for Minimally Invasive Biopsy Procedures

          3.2.4 Rapidly Aging Global Population

          3.2.5 Impact Analysis of Market Drivers

    3.3 Market Restraints

          3.3.1 Issues with Medical Reimbursements

          3.3.2 High Pricing of Technologically Advanced Biopsy Devices

          3.3.3 Impact Analysis of Market Restraints

    3.4 Market Opportunities

          3.4.1 Tapping The Market in Emerging Economies with High Unmet Medical Needs

    3.5 Porter’s Five Forces Analysis

          3.5.1 Bargaining Power Of Buyers

          3.5.2 Bargaining Power Of Suppliers

          3.5.3 Threat Of Substitutes

          3.5.4 Threat Of New Entrants

          3.5.5 Competitive Rivalry

    3.6 Market Attractiveness Analysis

     

    Chapter 4 Biopsy Devices Market, By Product Types

    4.1 Introduction

    4.2 Comparative Analysis: Biopsy Devices Market, By Product Types, 2011 & 2018 (Value %)

    4.3 Needle-Based Biopsy Guns

          4.3.1 Vacuum-Assisted Biopsy (VAB) Devices

          4.3.2 Core Needle Biopsy (CNB) Devices

          4.3.3 Fine Needle Aspiration Biopsy (FNAB) Devices

    4.4 Biopsy Needles

          4.4.1 Disposable Biopsy Needles

          4.4.2 Reusable Biopsy Needles

    4.5 Biopsy Forceps

          4.5.1 Cold (General) Biopsy Forceps

          4.5.2 Hot Biopsy Forceps

    4.6 Biopsy Guidance Systems

          4.6.1 Manual Guidance Systems

                   4.6.1.1 Mammotome Biopsy System (Devicor Medical Products)

                   4.6.1.2 Encor Enspire (Bard Biopsy Systems)

                   4.6.1.3 ATEC Sapphire (Hologic)

                   4.6.1.4 Affirm (Hologic)

          4.6.2 Robotic Guidance Systems

                   4.6.2.1 Da Vinci (Intuitive Surgical)

                   4.6.2.2 Neuromate (Renishaw)

                   4.6.2.3 Pathfinder (Prosurgics)

                   4.6.2.4 Innomotion (Synthes)

    4.7 Others

          4.7.1 Biopsy Brushes

          4.7.2 Biopsy Curettes

          4.7.3 Biopsy Punches

     

    Chapter 5 Biopsy Devices Market, By Geography

    5.1 Comparative Analysis: Biopsy Devices Market, By Geography, 2011 & 2018 (Value %)

    5.2 North America

          5.2.1 North America Biopsy Devices Market, by Segments, 2010 – 2018 (USD Million)

    5.3 Europe

          5.3.1 Europe Biopsy Devices Market, by Segments, 2010 – 2018 (USD Million) 

    5.4 Asia

          5.4.1 Asia Biopsy Devices Market, by Segments, 2010 – 2018 (USD Million)

    5.5 Rest of the World (RoW)

          5.5.1 RoW Biopsy Devices Market, by Segments, 2010 – 2018 (USD Million)

     

    Chapter 6 Competitive Landscape

    6.1 Market Share Analysis, by Key Players (%)

     

    Chapter 7 Recommendations

    7.1 Sustaining Pricing Pressures in a Declining Global Economic Scenario

    7.2 Investing in Emerging Markets Such as India, China and Russia

    7.3 Mergers and Acquisitions to Enter or Strengthen Market Presence

    7.4 Enhancing Distribution Networks

    7.5 Extensive Marketing Initiatives

          7.5.1 Strategic Tie-Ups with Hospitals and Individual Medical Practitioners

          7.5.2 Organizing Customer Awareness Programs and Rigorous Advertising

     

    Chapter 8 Company Profiles

    8.1 Angiotech

          8.1.1 Company Overview

          8.1.2 Financial Overview

          8.1.3 Product Portfolio

          8.1.4 Business Strategy

          8.1.5 Recent Developments

    8.2 Cardinal Health Inc.

          8.2.1 Company Overview

          8.2.2 Financial Overview

          8.2.3 Product Portfolio

          8.2.4 Business Strategy

          8.2.5 Recent Developments

    8.3 Carefusion Corporation

          8.3.1 Company Overview

          8.3.2 Financial Overview

          8.3.3 Product Portfolio

          8.3.4 Business Strategy

          8.3.5 Recent Developments

    8.4 C. R. BARD, Inc.

          8.4.1 Company Overview

          8.4.2 Financial Overview

          8.4.3 Product Portfolio

          8.4.4 Business Strategies

          8.4.5 Recent Developments

    8.5 Devicor Medical Products, Inc.

          8.5.1 Company Overview

          8.5.2 Financial Overview

          8.5.3 Product Portfolio

          8.5.4 Business Strategy

          8.5.5 Recent Developments

    8.6 DTR Medical

          8.6.1 Company Overview

          8.6.2 Financial Overview

          8.6.3 Product Portfolio

          8.6.4 Business Strategy

          8.6.5 Recent Developments

    8.7 Hologic, Inc.

          8.7.1 Company Overview

          8.7.2 Financial Overview

          8.7.3 Product Portfolio

          8.7.4 Business Strategy

          8.7.5 Recent Developments

    8.8 INRAD, Inc.

          8.8.1 Company Overview

          8.8.2 Financial Overview

          8.8.3 Product Portfolio

          8.8.4 Business Strategy

          8.8.5 Recent Developments

    8.9 UK Biopsy

          8.9.1 Company Overview

          8.9.2 Financial Overview

          8.9.3 Product Portfolio

          8.9.4 Business Strategy 

    List of Tables

     

    TABLE 1 Market Snapshot : Global Biopsy Devices Market

    TABLE 2 Cancer Incidence, by Types, 2008 and 2015 (Million)

    TABLE 3 Impact Analysis of Market Drivers

    TABLE 4 Impact Analysis of Market Restraints

    TABLE 5 Global Biopsy Devices Market, by Product Types, 2010 - 2018 (USD Million)

    TABLE 6 Global Needle-Based Biopsy Guns Market, by Segments, 2010 – 2018 (USD Million)

    TABLE 7 Global Needles Market, by Segments, 2010 – 2018 (USD Million)

    TABLE 8 Global Biopsy Forceps Market, by Segments, 2010 – 2018 (USD Million)

    TABLE 9 Global Other Biopsy Devices Market, by Segments, 2010 – 2018 (USD Million)

    TABLE 10 Global Biopsy Guidance Systems Market, by Segments, 2010 – 2018 (USD Million)

    TABLE 11 North America Biopsy Devices Market, by Segments, 2010 – 2018 (USD Million)

    TABLE 12 Europe Biopsy Devices Market, by Segments, 2010 – 2018 (USD Million)

    TABLE 13 Asia Biopsy Devices Market, by Segments, 2010 – 2018 (USD Million)

    TABLE 14 Row Biopsy Devices Market, by Segments, 2010 – 2018 (USD Million)

    List of Figures

     

    FIG. 1 Biopsy Devices: Market Segmentation

    FIG. 2 Global Biopsy Devices Market, by Product Types, 2011 (USD Million)

    FIG. 3 Porter’s Five Forces Analysis : Global Biopsy Devices Market

    FIG. 4 Market Attractiveness Analysis: Global Biopsy Devices Market, by Geography

    FIG. 5 Comparative Analysis: Biopsy Devices Market, by Product Types, 2011 & 2018 (Value %)

    FIG. 6 Global Vacuum-Assisted Biopsy Devices Market, 2010 – 2018 (USD Million)

    FIG. 7 Global Core Needle Biopsy Devices Market, 2010 – 2018 (USD Million)

    FIG. 8 Global Fine Needle Aspiration Biopsy Devices Market, 2010 – 2018 (USD Million)

    FIG. 9 Global Disposable Biopsy Needles Market, 2010 – 2018 (USD Million)

    FIG. 10 Global Reusable Biopsy Needles Market, 2010 – 2018 (USD Million)

    FIG. 11 Global Cold (General) Biopsy Forceps Market, 2010 – 2018 (USD Million)

    FIG. 12 Global Hot Biopsy Forceps Market, 2010 – 2018 (USD Million)

    FIG. 13 Global Biopsy Brushes Market, 2010 – 2018 (USD Million)

    FIG. 14 Global Biopsy Curettes Market, 2010 – 2018 (USD Million)

    FIG. 15 Global Biopsy Punches Market, 2010 – 2018 (USD Million)

    FIG. 16 Global Manual Guidance Systems Market, 2010 – 2018 (USD Million)

    FIG. 17 Global Robotic Guidance Systems Market, 2010 – 2018 (USD Million)

    FIG. 18 Comparative Analysis: Biopsy Devices Market, By Geography, 2011 & 2018 (Value %)

    FIG. 19 U.K.: Most Common Cancers in Males, 2010 (%)

    FIG. 20 U.K.: Most Common Cancers in Females, 2010 (%)

    FIG. 21 Biopsy Devices: Market Share, by Key Players, 2011 (%)

    FIG. 22 Angiotech Annual Revenues:  2009 - 2011 (USD Million)

    FIG. 23 Cardinal Health, Inc. Annual Revenues:  2009 - 2011 (USD Million)

    FIG. 24 Carefusion Corporation Annual Revenues: 2009 - 2011 (USD Million)

    FIG. 25 C. R. Bard, Inc. Annual Revenues:  2009 - 2011 (USD Million)

    FIG. 26 Hologic, Inc. Annual Revenues: 2009 - 2011 (USD Million)

Copyright © Transparency Market Research, Inc. All Rights reserved

Biopsy Devices Market

Schedule a Call